EP BIOCOMPOSITES LIMITED

Utilities · Other Utilities

BSE: 543595
₹98.18
▲ 1.67 (1.73%)
Sept. 28, 2026 · BSE · bse_bhavcopy
Quality
46/100
Moderate
Valuation
—/100
Data unavailable
Momentum
47/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹17 Cr
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-15.6
Free Cash Flow
₹2 Cr
as of March 31, 2026
Industry median ₹-5 Cr (18 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
3.34
as of March 31, 2026
Industry median 2.21 (18 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 3 met
  • No Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 1 met
  • No 1-year return beats the industry median

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.7%
Low 88.0000 · High 108.9900
1W return
-1.8%
Low 88.0000 · High 108.9900
1M return
-4.9%
Low 85.0500 · High 108.9900
52W return
-38.4%
Low 85.0500 · High 108.9900
Lifetime High ₹346.9500 (Sept. 29, 2022)
Lifetime Low ₹89.0000 (Sept. 2, 2026)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish5
5D
98.0
10D
98.8
20D
106.0
50D
125.5
100D
145.1
200D
177.2

Delivery and volume

Day avg. delivery
66.7%
Week avg. delivery
19.2%
Month avg. delivery
41.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

98.39
Pivot
First resistance108.78
Second resistance119.38
Third resistance129.77
First support87.79
Second support77.40
Third support66.80
Day RSI41.8
Day MFI69.0
Day MACD-11.02
Day MACD signal-13.11

Beta

1M—
3M—
1Y—
3Y0.29

Price change analysis

↓ -4.9%
Over 1 Month
LowHigh
85.05108.99
↓ -38.4%
Over 3 Months
LowHigh
85.05108.99
↓ -38.4%
Over 6 Months
LowHigh
85.05108.99
↓ -38.4%
Over 1 Year
LowHigh
85.05108.99
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #12 of 13 in Other Utilities by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter70.08%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 70.08% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
30 Mar 2026 SATYA PRAKASH MITTAL Bulk Sell 8,500 84.0000 BSE
30 Mar 2026 NEELAM MITTAL Bulk Buy 8,500 84.0000 BSE
4 Dec 2025 NOPEA CAPITAL SERVICES PRIVATE LIMITED Bulk Sell 11,000 100.0000 BSE
4 Dec 2025 OVERSKUD MULTI ASSET MANAGEMENT PRIVATE LIMITED Bulk Buy 11,000 100.0000 BSE
19 Aug 2025 XTENDED BUSINESS REPORTING LIMITED Bulk Sell 14,000 129.9500 BSE
19 Aug 2025 RAJIV MEHTA Bulk Buy 14,500 129.8800 BSE
7 Jul 2025 ANKITAGUPTA Bulk Sell 14,000 99.5200 BSE
5 Mar 2025 SATYA PRAKASH MITTAL HUF Bulk Sell 8,500 118.0000 BSE
5 Mar 2025 SATYA PRAKASH MITTAL Bulk Buy 8,500 118.0000 BSE
5 Mar 2025 AJAY MEHTA Bulk Sell 10,000 112.0000 BSE

All bulk and block deals →

Corporate Announcements

All 7 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Insider Trading / SAST EP Biocomposites Ltd - 543595 - Closure of Trading Window
29 Sep 2026 Company Update EP Biocomposites Ltd - 543595 - Intimation Of Strategic Collaboration And Consultancy Agreement Entered With Malligavad Foundation And Anand Malligavad
21 Sep 2026 Company Update EP Biocomposites Ltd - 543595 - Presentation Prepared For The Upcoming Annual General Meeting Of The Company
4 Sep 2026 AGM/EGM EP Biocomposites Ltd - 543595 - Intimation Of The Seventh Annual General Meeting To Be Held On September 28, 2026
4 Sep 2026 Others EP Biocomposites Ltd - 543595 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 38.4% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about EP BIOCOMPOSITES LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.